ISAR Publisher

International Scientific and Academic Research Publisher

Submit Manuscript
ISAR Journal of Medical and Pharmaceutical Sciences
Abbr. Title:
ISAR J Med Pharm Sci
ISSN(Online):
2584-0150
Publisher:
ISAR Publisher
Chief Editor:
Dr. Shivendra Agarwal
Country of origin:
India
Language:
English
Frequency:
Monthly
Format:
Online
Journal starting year:
2023

Generative AI Policy

Background and Rationale

Generative Artificial Intelligence (GenAI) presents both opportunities and challenges in scientific writing and academic publishing. To enhance transparency, research integrity, and trust in scholarly communication, ISAR Publisher has established this policy governing the responsible use of GenAI and AIassisted technologies. This policy aligns with recommendations from major indexing bodies and publishing standards, including Scopus, COPE, and leading international publishers.

ISAR Publisher recognizes that GenAI technologies are evolving rapidly. Therefore, this policy focuses on principles of transparency, accountability, and ethical use rather than prescribing specific tools or rigid technical requirements.

Scope of the Policy

This policy applies to:

  • Authors submitting manuscripts to ISAR Publisher journals
  • Editors, editorial board members, and publishing staff
  • Peer reviewers involved in the editorial and peer review process

Definition of Generative AI and AIAssisted Technologies

Generative AI and AIassisted technologies refer to software or systems capable of generating, editing, summarizing, translating, or enhancing text, images, or other content based on prompts or data inputs. Examples include, but are not limited to, large language models, AIbased language editing tools, and automated contentgeneration systems.

Acceptable Use by Authors

Authors may use GenAI or AIassisted tools for limited and supportive purposes, such as:

  • Improving grammar, spelling, clarity, and language quality
  • Enhancing readability and structure
  • Assisting with formatting or reference management

Conditions:

  • GenAI tools must not replace the authors’ original intellectual contribution, analysis, or scholarly judgment
  • Authors must critically review, verify, and edit all AIassisted content
  • Authors remain fully responsible for the accuracy, originality, and integrity of the manuscript

Prohibited Use

The following uses of GenAI are not permitted:

  • Generating original research data, results, interpretations, or conclusions
  • Fabricating, falsifying, or manipulating data or images
  • Creating or altering figures, tables, or images in a misleading manner
  • Producing entire manuscripts or substantial sections without meaningful human authorship
  • Listing GenAI tools or systems as authors or coauthors

Disclosure of GenAI Use

To ensure transparency, authors must disclose the use of GenAI or AIassisted technologies in manuscript preparation. Disclosure should be provided in a dedicated section titled “Declaration of Generative AI and AIAssisted Technologies in Writing” and must include:

  • The name of the AI tool used
  • The specific purpose for which it was used

Example:

During the preparation of this manuscript, the authors used [tool name] to assist with language editing and readability. All content was reviewed and approved by the authors, who take full responsibility for the final version.

Failure to disclose GenAI use may be considered a breach of publication ethics.

Use of GenAI in Peer Review and Editorial Processes

  • Reviewers and editors must not upload manuscripts, reviewer reports, or confidential information into external GenAI systems
  • GenAI tools must not be used to generate peer review reports or editorial decisions
  • Editorial judgment and peer review must be conducted solely by qualified human experts

Plagiarism, Originality, and Detection

  • All submissions may be screened using plagiarism detection and AIcontent detection tools
  • Manuscripts containing excessive AIgenerated content or undisclosed AI use may be rejected or returned for revision
  • ISAR Publisher follows COPE guidelines when investigating suspected misuse of GenAI

Responsibility and Accountability

The use of GenAI does not diminish or transfer responsibility. Authors, editors, and reviewers remain fully accountable for all content, decisions, and ethical compliance associated with published works.

Compliance and Policy Updates

Noncompliance with this policy may result in manuscript rejection, correction, retraction, or other editorial actions. ISAR Publisher reserves the right to revise this policy periodically to reflect technological developments, ethical standards, and indexing requirements.

ISAR Publisher

Website: https://isarpublisher.com
Email: contact@isarpublisher.com

Latest Articles
Original Article2 downloads
DOPPLER AND MRI PATTERNS IN PATIENTS WITH MIGRAINE
PDFView Article

An examination of 104 patients with migraine aged 16 to 45 years was carried out duplex scanning (DS) and magnetic resonance methods tomography (MRI). The composition was evaluated substances of the brain and cerebral hemodynamics in patients with migraine without aura (59 patients) and with migraine with aura (45 patients).Structural​  changes white substances of the brain in the form of hyperintense  on T2VI and predominantly isointense  on T1VI focus   there were 3 to 12 mm revealed in 28.8% of patients with migraine without aura and 53.3% of patients with migraine with aura. The foci were localized mainly in the white matter of the superior lobes (35.2% of patients with migraine without aura and 41.6% of patients with migraine with aura). According to Doppler studies in patients with migraine without aura prevailed vasospastic reactions in the middle brain arteries ​With migraine with aura more often was noted difficult perfusion in the middle cerebral and vertebral artery.

Original Article38 downloads
Eclampsia and Maternal Mortality: Challenges and Pathways to Safer Care in Low-Resource Settings
DOI: https://doi.org/10.5281/zenodo.22092222
PDFView Article

Eclampsia remains a major contributor to maternal and perinatal mortality, particularly in resource-limited settings where disparities in healthcare access and quality persist. This review examines the current evidence on the pathophysiology, global burden, diagnostic challenges, and management strategies of eclampsia, with a focus on low- and middle-income countries. A narrative review methodology was employed, synthesizing findings from existing literature and clinical reports.

The findings highlight significant barriers to effective management, including limited diagnostic infrastructure, inconsistent availability and use of magnesium sulfate, delayed patient presentation, and severe healthcare workforce shortages. These systemic challenges contribute to high case fatality rates and poor maternal outcomes. Additionally, sociocultural factors, inadequate health literacy, and weak health systems further exacerbate delays in diagnosis and treatment.

The study emphasizes the need for context-specific interventions, including community-based surveillance, task-sharing, mHealth innovations, and the implementation of standardized care protocols. Strengthening healthcare systems and improving access to timely, evidence-based interventions are critical to reducing preventable deaths associated with eclampsia in resource-constrained environments.

Original Article30 downloads
Hereditary Disorders in Moderate-Altitude Taif, Saudi Arabia: Molecular Genetic Evidence and a Community Genomics Research Agenda
DOI: https://doi.org/10.5281/zenodo.22091909
PDFView Article

Taif is situated at approximately 1,800 m above sea level, below the conventional threshold for high altitude but sufficiently elevated to justify investigation of oxygen-sensitive phenotypes. Its community-genetics profile is also shaped by consanguinity, family-specific founder variants, and a substantial burden of autosomal-recessive disease. This critical narrative review separates three related questions: the hereditary-disorder spectrum relevant to Saudi and Arab populations, the molecular biology of adaptation to severe high-altitude hypoxia, and the currently untested possibility that moderate-altitude residence modifies disease expression in Taif. Evidence from Saudi genomic programs supports family-based exome or genome sequencing, homozygosity mapping, segregation analysis, and population-specific variant interpretation. Priority clinical groups include neurodevelopmental disorders, inherited retinal disease, hemoglobinopathies, inborn errors of metabolism, mitochondrial disease, and congenital anomalies. Studies of Tibetan, Andean, and Ethiopian populations establish the importance of hypoxia-inducible factor signaling, particularly EPAS1 and EGLN1, but these findings cannot be transferred directly to Taif. Direct local human genomic evidence remains sparse, and the available Taif study of oxidative stress used an animal model rather than a resident population. We propose a staged community genomics program integrating a regional registry, standardized phenotyping, family-centered sequencing, ancestry-aware analyses, a lower-altitude Saudi comparison group, and clinically governed return of results. This approach could improve diagnosis, carrier screening, counseling, and precision prevention while testing whether moderate altitude modifies hematologic, cardiopulmonary, or metabolic phenotypes.

Original Article56 downloads
Role of Simulation Training in Anesthesia and Operation Theatre Education: Current Applications and Clinical Impact
DOI: https://doi.org/10.5281/zenodo.22091859
PDFView Article

Simulation-based training has become a vital part of modern anesthesia and operation theatre education, offering a safe setting to build clinical skills without risking patient safety. This review explores current uses, clinical benefits, and challenges of simulation in anesthesia and OT training, with a focus on its importance for anesthesiologists and OT technologists. From basic task trainers to advanced simulators, virtual and augmented reality, AI-assisted tools, and in-situ simulations are increasingly adopted in healthcare training. In anesthesia, simulation supports repeated practice of airway management, CPR, regional anesthesia, equipment handling, and crisis management. In the OT, it educates on sterile techniques, infection control, instrument handling, emergency response, teamwork, communication, and interdisciplinary crisis management. Evidence indicates that simulation enhances both technical and non-technical skills, such as procedural competence, confidence, teamwork, crisis decision-making, and readiness for high-stakes scenarios. For technologists, it provides important opportunities to develop skills in setting up anesthesia workstations, managing airway and emergency equipment, monitoring, organizing instruments, troubleshooting during surgery, and collaborating across disciplines. However, barriers such as high costs, limited access, shortage of trained faculty, technical issues, lack of standardized curricula and assessments, and logistical hurdles hamper implementation. Therefore, simulation should complement, not replace, supervised clinical training. Anticipated future advancements with AI, immersive VR/AR, telesimulation, competency evaluation, and affordable models will likely broaden its educational and safety benefits. Overall, simulation-based training is a powerful method to enhance clinical skills, teamwork, patient safety, and ongoing professional development in anesthesia and OT practice.

Original Article33 downloads
Healthy Living Beyond 100: Aligning Evolutionary Physiology with Modern Lifestyle
DOI: https://doi.org/10.5281/zenodo.22091816
PDFView Article

Non-communicable diseases (NCDs) represent the dominant global health burden of the 21st century, driven by rapid urbanization, modern dietary shifts, and chronic psychosocial stress. Cardiovascular disease including Hypertension , Type 2 Diabetes, And Cancer etc, stem largely from an evolutionary mismatch between ancient human physiology and a contemporary, ultra-processed food environment. While systemic socioeconomic factors influence disease trajectories, individual lifestyle optimization remains a primary lever for preventive healthcare.

This mini-review synthesizes evidence on the environmental, nutritional, and behavioral determinants of healthy longevity. By examining the demographically validated centenarian populations of the world's "Blue Zones," this paper highlights the physiological mechanisms specifically the suppression of chronic hyperinsulinemia, reduction of allostatic load, and optimization of micro-nutrient balances, that preserve organ reserve and extend health span. Ultimately, bridging ancestral lifestyle wisdom with modern clinical precision offers a scalable roadmap for chronic disease prevention.